Name | 2-[[2-(4-bromophenyl)-6-methylpyrimidin-4-yl]amino]ethanol |
---|---|
Synonyms |
hms1581i01
Ethanol, 2-[[2-(4-bromophenyl)-6-methyl-4-pyrimidinyl]amino]- 2-{[2-(4-Bromophenyl)-6-methyl-4-pyrimidinyl]amino}ethanol AS-1269574 |
Description | AS1269574 is a potent, orally available GPR119 agonist, with an EC50 of 2.5 μM in HEK293 cells expressing human GPR119. AS1269574 activates TRPA1 cation channels to stimulate glucagon-like peptide-1 (GLP-1) secretion. AS1269574 specifically induces glucose-dependent insulin secretion from pancreatic β-cells only under high-glucose conditions. AS1269574 has the potential for the research of type 2 diabetes[1][2]. |
---|---|
Related Catalog | |
Target |
TRPA1 GPR119 |
In Vivo | AS1269574 sgnificantly reduced the blood glucose AUC after 2 h (AUC0-2h) of administration[1]. Animal Model: Eight-week-old ICR mice[1] Dosage: 100 mg/kg Administration: P.o. Result: Sgnificantly reduced the blood glucose AUC after 2 h (AUC0-2h) of administration. Similarly, plasma insulin AUC0-2h was significantly higher in the mice. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 386.9±42.0 °C at 760 mmHg |
Molecular Formula | C13H14BrN3O |
Molecular Weight | 308.174 |
Flash Point | 187.8±27.9 °C |
Exact Mass | 307.032013 |
PSA | 58.04000 |
LogP | 2.32 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.648 |
Storage condition | -20℃ |
Precursor 3 | |
---|---|
DownStream 0 |